Schizophrenia is a form of mental disorder that is behaviorally characterized by abnormal behavior, such as social function deficits or other behaviors that are disconnected from reality. Dysregulation of oxytocin may play a role in regulating the expression of schizophrenia. Given oxytocin's role in social cognition and behavior, a variety of studies have examined the potential clinical benefits of oxytocin in improving the psychopathology of patients with schizophrenia. In this review, we highlight the evidence for the role of endogenous oxytocin in schizophrenia, from animal models to human studies. We further discuss the potential of oxytocin as a therapeutic agent for schizophrenia and its implication in future treatment.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7926349 | PMC |
| http://dx.doi.org/10.3390/ijms22042146 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Oxytocin Protects Against Corticosterone-Induced DA Dysfunction: An Involvement of the PKA/CREB Pathway.
Neurochem Res
November 2024
Research Center for Neuroscience, Institute of Molecular Biosciences, Mahidol University, Nakhon Pathom, 73170, Thailand.
Article Synopsis
- - Chronic stress negatively affects dopamine transmission, leading to mood disorders and conditions like ADHD, autism, schizophrenia, anxiety, depression, and drug addiction, while oxytocin plays a role in social behaviors and can counteract stress effects.
- - This study examined how oxytocin can protect against dopamine dysfunction caused by corticosterone in neuroblastoma cells, revealing that corticosterone reduces key signaling molecules related to dopamine function, but oxytocin can mitigate this dysfunction.
- - The protective effect of oxytocin operates through activation of protein kinase A (PKA) and involves oxytocin receptors, providing insights into stress resilience and possible treatments for disorders linked to dopamine issues.
Interactions of Oxytocin and Dopamine-Effects on Behavior in Health and Disease.
Biomedicines
October 2024
Department of Applied Animal Science and Welfare, Swedish University of Agricultural Sciences, 532 31 Skara, Sweden.
The hypothalamic neuropeptide and hormone oxytocin are of fundamental importance for maternal, social, and sexual behavior. Deviations in oxytocin levels have also been associated with anxiety, autism spectrum disorders (ASD), depression, ADHD (attention deficit hyperactivity disorder), and schizophrenia. Both oxytocin and dopamine are often considered reward- and feel-good hormones, and dopamine is associated with the above-mentioned behaviors and, and dopamine is also associated with the above-mentioned behaviors and disorders.
View Article and Find Full Text PDFMaternal care is associated with neural and behavioral effects of oxytocin administration during empathic accuracy in schizophrenia and controls.
Psychoneuroendocrinology
November 2024
University of California, San Francisco, Department of Psychiatry, USA; San Francisco Veterans Affairs Medical Center, USA; UCSF Weill Institute for Neurosciences, USA. Electronic address:
Article Synopsis
- * The study examined whether oxytocin, delivered intranasally, could enhance empathic accuracy in those with schizophrenia compared to a placebo, while considering the influence of early maternal care.
- * Results showed no overall improvement in empathic accuracy from oxytocin for either group; however, those with better maternal care had the most notable improvements, suggesting early social experiences can affect responses to oxytocin treatment.
Intranasal Oxytocin Combined With Social Skills Training for Schizophrenia: An Add-on Randomized Controlled Trial.
Schizophr Bull Open
January 2024
Zachai Department of Psychiatry, Sheba Medical Center, Ramat Gan, Israel.
Some but not other studies on oxytocin for schizophrenia, particularly those using a higher dose, indicate that oxytocin improves negative symptoms of schizophrenia. We performed an add-on randomized controlled trial to examine the effect of high-dose oxytocin, social skills training, and their combination in the treatment of negative symptoms and social dysfunction in schizophrenia. Fifty-one subjects with schizophrenia were randomized, employing a two-by-two design: intranasal oxytocin (24 IU X3/day) or placebo, and social skills training or supportive psychotherapy, for 3 weeks.
View Article and Find Full Text PDFContrasting Effects of Oxytocin on MK801-Induced Social and Non-Social Behavior Impairment and Hyperactivity in a Genetic Rat Model of Schizophrenia-Linked Features.
Brain Sci
September 2024
Medical Psychology Unit, Department of Psychiatry & Forensic Medicine, Institute of Neurosciences, Autonomous University of Barcelona, 08193 Bellaterra, Barcelona, Spain.
Social withdrawal in rodents is a measure of asociality, an important negative symptom of schizophrenia. The Roman high- (RHA) and low-avoidance (RLA) rat strains have been reported to exhibit differential profiles in schizophrenia-relevant behavioral phenotypes. This investigation was focused on the study of social and non-social behavior of these two rat strains following acute administration of dizocilpine (MK801, an NMDA receptor antagonist), a pharmacological model of schizophrenia-like features used to produce asociality and hyperactivity.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!